← Browse by Condition
Medical Condition

relapsed refractory hematological malignancies

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT05528887 Phase 1
Recruiting

Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies

Enrollment
10 pts
Location
China
Sponsor
The Affiliated People's Hospit...
View Trial →